Volume 82, Issue 3 pp. 538-541
Free Access

A T cell receptor beta chain polymorphism is associated with patients developing insulin-dependent diabetes after the age of 20 years

S. A. McMILLAN

Corresponding Author

S. A. McMILLAN

Regional Immunology Laboratory, Belfast City Hospital, Belfast, Northern Ireland

S. A. McMillan, Regional Immunology Laboratory, Belfast City Hospital, Belfast BT9 7AD, Northern Ireland.Search for more papers by this author
C. A. GRAHAM

C. A. GRAHAM

Department of Medical Genetics, Queens' University of Belfast, Belfast, Northern Ireland

Search for more papers by this author
P.J. HART

P.J. HART

Regional Immunology Laboratory, Belfast City Hospital, Belfast, Northern Ireland

Search for more papers by this author
D.R. HADDEN

D.R. HADDEN

Sir George E. Clark Metabolic Clinic, Royal Victoria Hospital, Belfast, Northern Ireland

Search for more papers by this author
T.A. McNEILL

T.A. McNEILL

Regional Immunology Laboratory, Belfast City Hospital, Belfast, Northern Ireland

Search for more papers by this author
First published: December 1990
Citations: 8

SUMMARY

We have studied the BglII polymorphism near the T cell receptor beta chain constant region (TcR-Cβ) gene, HLA-DR genotypes and certain autoimmune features in 102 patients with type I (insulin-dependent) diabetes. There was a significant decrease in the frequency of the 1:1 genotype (P= 0.008) and an increase in the 1:2 genotype (P= 0.03) of the BglII TcR polymorphism in the group of patients who developed type-I diabetes after the age of 20 years. This group of patients also showed an increased incidence of autoantibodies (especially islet cell antibody), a family history of diabetes and the presence of other autoimmune diseases. The frequency of this polymorphism in patients who developed type I diabetes before the age of 20 years was similar to a non-diabetic group. These results suggest that there are two genetically distinct groups of patients with type I diabetes. HLA-DR3 and HLA-DR4 genotypes were also increased in the diabetic patients but no significant difference was observed between HLA-DR genotypes, the TcR- genotypes, the age of diagnosis or with other autoimmune features. Patients developing type I (insulin-dependent) diabetes after the age of 20 years have an additional genetic susceptibility for diabetes associated with the TcR- gene.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.